MRKR

Marker Therapeutics Inc
2.64
-0.06 (-2.22%)

Marker Therapeutics Inc. (MRKR) Fundamentals

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets. It is also developing peptide-based immunotherapeutic vaccines for the treatment of metastatic solid tumors, as well as PolyStart.
SHARE INFORMATION
Market Cap$ 22,546,466
Shares Outstanding8,540,328
Float6,064,850
Percent Float71.01%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 1,241,710
Latest Fiscal EPS$ -5.60
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions81
Institutional Holdings Date2023-01-31
Institutional Bought Previous 3 Months54,009
Institutional Holdings Percent8.1%
Institutional Sold Previous 3 Months4,427,449
Insider Holdings Date2022-12-31
Insider Bought Previous 3 Months-
Insider Holdings Percent21.3
Insider Sold Previous 3 Months-
Insider Shares Owned18,181,622
TRADING INFO
52 Week High$ 6.60
52 Week Low$ 2.20
52 Week High Change$ -55.58
21 Day Moving Average$ 3.258
21 Day Extended Moving Average$ 3.1457
50 Day Moving Average$ 3.0546
50 Day Extended Moving Average$ 3.2125
200 Day Moving Average$ 3.4264
200 Day Extended Moving Average$ 4.4481
10 Day Average Volume69,075
20 Day Average Volume50,250
30 Day Average Volume44,476
50 Day Average Volume38,251
Alpha-0.023204
Beta1.0446
Standard Deviation0.254178
R20.049276
7 Day Price Change$ -0.888
7 Day Percent Change-25.17%
21 Day Price Change$ -0.825
21 Day Percent Change-23.81%
30 Day Price Change$ -0.01899
30 Day Percent Change-0.71%
Month to Date Price Change$ -0.16
Month to Date Percent Change-5.71%
Quarter to Date Price Change$ -0.01899
Quarter to Date Percent Change-0.71%
180 Day Price Change$ -0.47
180 Day Percent Change-15.11%
200 Day Price Change$ -0.69
200 Day Percent Change-20.72%
Year to Date Price Change$ -0.01899
Year to Date Percent Change-0.71%

Marker Therapeutics Inc. (MRKR) Key Ratios

PROFITABILITY
EBIT Margin-855.5%
EBITDA Margin-771.1%
Pre-Tax Profit Margin-18,954.5%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 2,950,000
Revenue Per Share$ 0.3454
Revenue (3 Years)$ 121.55
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.00
Total Debt To Equity0.30
Int Coverage0.00
Current Ratio2.00
Leverage Ratio1.70
Quick Ratio1.80
Long Term Debt To Capital0.24
VALUATION MEASURES
PE Ratio-0.60
Enterprise Value$ 12,698,945
Price to Sales7.6429
Price to Free Cash-0.90
PE High Last 5 Years-1.20
Price To Book1.00
Price To Cash Flow0.00
PE Low Last 5 Years-2.80
Price to Tangible Book1.00
MANAGEMENT EFFECTIVENESS
Receivables Turnover2.20
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-63.40
Return on Equity-95.72
Return on Capital-76.05

Marker Therapeutics Inc. (MRKR) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorMarcum LLP
CEOPeter L. Hoang
Emplyoees56
Last AuditUE
CIK0001094038
IndustryBiotechnology
SectorHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
Address3200 Southwest Freeway
Suite2500
Houston, TX 77027
Websitehttp://www.markertherapeutics.com
Facsimile-
Telephone+1 713 400-6400
Emailinvestor.relations@markertherapeutics.com


Your Recent History
NASDAQ
MRKR
Marker The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.